Metabolic reprogramming by Dichloroacetic acid potentiates photodynamic therapy of human breast adenocarcinoma MCF-7 cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolic reprogramming by Dichloroacetic acid potentiates photodynamic therapy of human breast adenocarcinoma MCF-7 cells
Authors
Keywords
-
Journal
PLoS One
Volume 13, Issue 10, Pages e0206182
Publisher
Public Library of Science (PLoS)
Online
2018-10-24
DOI
10.1371/journal.pone.0206182
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Abscopal, immunological effects of radiotherapy: Narrowing the gap between clinical and preclinical experiences
- (2017) Nikko Brix et al. IMMUNOLOGICAL REVIEWS
- Trends and Patterns of Disparities in Cancer Mortality Among US Counties, 1980-2014
- (2017) Ali H. Mokdad et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Radiotherapy and immunotherapy: a beneficial liaison?
- (2017) Ralph R. Weichselbaum et al. Nature Reviews Clinical Oncology
- Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics
- (2017) Abhishek D. Garg et al. OncoImmunology
- Endoplasmic reticulum stress-induced apoptosis accompanies enhanced expression of multiple inositol polyphosphate phosphatase 1 (Minpp1): a possible role for Minpp1 in cellular stress response
- (2016) Surya P. Kilaparty et al. CELL STRESS & CHAPERONES
- Cytotoxicity of Manganese (III) Complex in Human Breast Adenocarcinoma Cell Line Is Mediated by the Generation of Reactive Oxygen Species Followed by Mitochondrial Damage
- (2016) Qudes Al-anbaky et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- On metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancer
- (2016) Judith Penkert et al. Oncotarget
- Radiotherapy Complements Immune Checkpoint Blockade
- (2015) Shin Foong Ngiow et al. CANCER CELL
- Combination cancer immunotherapy and new immunomodulatory targets
- (2015) Kathleen M. Mahoney et al. NATURE REVIEWS DRUG DISCOVERY
- Releasing the Brakes on Cancer Immunotherapy
- (2015) Antoni Ribas NEW ENGLAND JOURNAL OF MEDICINE
- Dual mTOR inhibitor MLN0128 suppresses Merkel cell carcinoma (MCC) xenograft tumor growth
- (2015) Aarthi Kannan et al. Oncotarget
- ER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses
- (2014) Abhishek D. Garg et al. PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES
- Dichloroacetate Enhances Adriamycin-Induced Hepatoma Cell Toxicity In Vitro and In Vivo by Increasing Reactive Oxygen Species Levels
- (2014) Yunhai Dai et al. PLoS One
- Trial Watch: Radioimmunotherapy for oncological indications
- (2014) Norma Bloy et al. OncoImmunology
- Consensus guidelines for the detection of immunogenic cell death
- (2014) Oliver Kepp et al. OncoImmunology
- Combinations of Immunotherapy and Radiation in Cancer Therapy
- (2014) Ralph E. Vatner et al. Frontiers in Oncology
- Targeting tumour energy metabolism potentiates the cytotoxicity of 5-aminolevulinic acid photodynamic therapy
- (2013) J P Golding et al. BRITISH JOURNAL OF CANCER
- Chemoimmunotherapy: reengineering tumor immunity
- (2013) Gang Chen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Molecular mechanisms of ATP secretion during immunogenic cell death
- (2013) I Martins et al. CELL DEATH AND DIFFERENTIATION
- Dichloroacetate improves immune dysfunction caused by tumor-secreted lactic acid and increases antitumor immunoreactivity
- (2013) Toshimitsu Ohashi et al. INTERNATIONAL JOURNAL OF CANCER
- Radiation and immunotherapy: a synergistic combination
- (2013) Anusha Kalbasi et al. JOURNAL OF CLINICAL INVESTIGATION
- Synergistic enhancement of antitumor effect of β-Lapachone by photodynamic induction of quinone oxidoreductase (NQO1)
- (2013) María Julia Lamberti et al. PHYTOMEDICINE
- Immunogenic cell death in radiation therapy
- (2013) Lorenzo Galluzzi et al. OncoImmunology
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Radiotherapy Increases the Permissiveness of Established Mammary Tumors to Rejection by Immunomodulatory Antibodies
- (2012) I. Verbrugge et al. CANCER RESEARCH
- Enlightening the impact of immunogenic cell death in photodynamic cancer therapy
- (2012) Lorenzo Galluzzi et al. EMBO JOURNAL
- A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
- (2012) Abhishek D Garg et al. EMBO JOURNAL
- The cellular and signaling networks linking the immune system and metabolism in disease
- (2012) Olivia Osborn et al. NATURE MEDICINE
- Combination of Sulindac and Dichloroacetate Kills Cancer Cells via Oxidative Damage
- (2012) Kasirajan Ayyanathan et al. PLoS One
- The convergence of radiation and immunogenic cell death signaling pathways
- (2012) Encouse B. Golden et al. Frontiers in Oncology
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Anticancer drugs that target metabolism: Is dichloroacetate the new paradigm?
- (2010) Ioanna Papandreou et al. INTERNATIONAL JOURNAL OF CANCER
- Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo
- (2009) Ramon C. Sun et al. BREAST CANCER RESEARCH AND TREATMENT
- Photodynamic therapy with 5-aminolevulinic acid and diamino acid derivatives of protoporphyrin IX reduces papillomas in mice without eliminating transformation into squamous cell carcinoma of the skin
- (2009) Mateusz Kwitniewski et al. INTERNATIONAL JOURNAL OF CANCER
- Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer
- (2008) E D Michelakis et al. BRITISH JOURNAL OF CANCER
- Dichloroacetate induces apoptosis in endometrial cancer cells
- (2008) Jason Y.Y. Wong et al. GYNECOLOGIC ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started